A paper gets prepared for publication to demonstrate clinical value of CorLog Probe 1P, title, authors:
Continuous long term wireless measurement of right ventricular and pulmonary arterial pressure in patients with severe COVID-19 pneumonia using a newly developed right ventricular pressure transducer, by Gärtner M+, Glocker R++, Glocker F++, Hopf HB+
+ Dept. of Anesthesia, perioperative medicine and interdisciplinary intensive care medicine, ECLS-ECMO center Langen, Asklepios Klinik Langen, Roentgenstrasse 20, 63225 Langen
++ emka MEDICAL GmbH, 63739 Aschaffenburg, Germany
“Since 2020 newly developed ultrathin catheter tip transducer for long term application have been used, introduced percutaneously via the internal jugular or subclavian vein into the right ventricle for wireless continuous measurements of right ventricular pressures and the estimated diastolic (ePAD) und mean (mPAP) pulmonary artery pressure in patients with severe ARDS caused by COVID-19 pneumonia who all were invasively or noninvasively mechanically ventilated. Preliminary results will be presented”
That means in more than 30 patients in run times up to 30 days four pressures are lined up in historical evolution and there is correlation (significance proven) between cardiac pressure control and survival.